
### [NCIT:C129444](http://purl.obolibrary.org/obo/NCIT_C129444)
**Label:** Medulloblastoma, Non-WNT/Non-SHH

**Subclasses:** [NCIT:C129445](http://purl.obolibrary.org/obo/NCIT_C129445) (Medulloblastoma, Non-WNT/Non-SHH, Group 3), 

**Class expressions from DL-Learner:**

- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C36593](http://purl.obolibrary.org/obo/NCIT_C36593) (Increased NFkappaB Pathway Activation))) 55.56%
- Thing 53.40%
- [NCIT:C82326](http://purl.obolibrary.org/obo/NCIT_C82326) (Sonic Hedgehog/Patch Pathway Activated) 52.78%
- [NCIT:C78303](http://purl.obolibrary.org/obo/NCIT_C78303) (Gait Disturbance) 52.78%
- [NCIT:C3834](http://purl.obolibrary.org/obo/NCIT_C3834) (Ataxic Gait) 52.78%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 52.78%
- [NCIT:C34661](http://purl.obolibrary.org/obo/NCIT_C34661) (Headache) 52.78%
- [NCIT:C3442](http://purl.obolibrary.org/obo/NCIT_C3442) (Vomiting) 52.78%
- [NCIT:C28082](http://purl.obolibrary.org/obo/NCIT_C28082) (Grade 4) 52.78%
- [NCIT:C129437](http://purl.obolibrary.org/obo/NCIT_C129437) (WNT Pathway Activated) 52.78%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) 46.38%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 46.38%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 46.38%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C39813](http://purl.obolibrary.org/obo/NCIT_C39813) (SMARCB1 Gene Inactivation))) 46.38%
- [NCIT:C82325](http://purl.obolibrary.org/obo/NCIT_C82325) (Signaling Pathway Status) and (not ([NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma))) 46.38%


